BRÈVE

sur MEDIAN TECHNOLOGIES (EPA:ALMDT)

Eyonis Inc Wins Prestigious "Rising Star" Award for Lung Cancer Screening Innovation

Graphique de l'évolution du cours de l'action MEDIAN TECHNOLOGIES (EPA:ALMDT).

November 17, 2026 – Eyonis Inc, a Median Technologies company, has been awarded the "Rising Star" title at the 2026 Digital Health Hub Foundation Digital Health & AI Awards. The accolade acknowledges the firm's groundbreaking eyonis® LCS solution, which offers AI-powered lung cancer screening.

Recognized for its ability to improve early lung cancer diagnosis, eyonis® LCS is the first and only software to receive both FDA clearance and CE marking. This innovation combines nodule detection and diagnostic evaluation, significantly reducing false positives and negatives compared to traditional methods.

Eyonis Inc was selected from over 1,300 companies worldwide for the Cancer, Screening & Early Detection category. The award was presented at the global HLTH 2026 conference in Las Vegas. The company’s software demonstrates a noteworthy 93.3% sensitivity and 92.4% specificity.

R. H.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de MEDIAN TECHNOLOGIES